Do you have a burning question on venture capital you need answered? Join OUP for our fourth annual ‘Ask a VC’ webinar, a session where our partner TTOs can ask Managing Partners Marc Singer and Bill Harrington anything and everything as it pertains to venture capital operations, decision-making, and the current investing environment. Since the…
Are you an academic researcher, PI, professor, or graduate student with an interest in entrepreneurship? If so, you should know about two excellent fellowship programs for academic founders. On September 28 at 2pm ET, OUP hosted a webinar featuring two such programs:
This is part 1 of a 5-part webinar series called Startup Licensing 101: A Resource for Entrepreneurs Working with Companies Originated at Academic Institutions.
For many entrepreneurs, licensing from a university may be a new experience. This series of webinars provides information that will be helpful for academic entrepreneurs contemplating their first (or perhaps subsequent) license from an academic institution. Presented by an attorney who represents many academic startups, including their investors, along with two academic technology transfer veterans, these webinars bring views from both sides of the table and best practices for a fruitful and efficient negotiation.
Corporate VCs have played a crucial role in financing life sciences companies for decades, but have you ever wondered what, if anything, makes them different from institutional venture capital funds? Join us for this webinar as we talk to a panel of investors at industry-leading CVC funds to learn more about their strategies, investment criteria, and how they measure success.
It’s hard to work, write, or think about anything without the context of COVID-19 these days. Living at the intersection of academic institutions and new ventures, I have daily insights into the plethora of programming at universities intended to advance scientific discoveries and see them translated into practice, especially through the activities of the technology…
Software-based technologies present challenges to the most experienced university technology managers when it comes to licensing. These technologies are often not patentable, released under an open source license, or the software is frequently rewritten – making the original code less valuable. Therefore, faculty frequently don’t disclose software, and companies commonly avoid licensing software IP from the universities.
A discussion on the differences in licensing to startups based out of Israel, China, and the UK by experts who have worked in these regions. David Ai, formerly of City University in Hong Kong, Amir Naiberg, formerly of Yeda Research and Development Co, in Israel, and Teri Willey, formerly of Cambridge Enterprise, will talk about particular variances in license clauses and startup structures that US tech transfer offices may encounter when licensing to entities incorporated in these countries.
In 2014 venture funding in healthcare IT shattered records, surpassing $4.1 billion, followed by an equally impressive performance in 2015 with $4.5 billion invested in the sector. While investment in digital healthcare cooled slightly in 2016 compared to previous record highs, investment in the sector remains significant with $4.3 billion invested in 2016. It’s a diverse, emerging sector with a barrage of startups competing in a broad marketplace to improve healthcare delivery as the nation’s $3 trillion healthcare delivery system gradually transitions from volume-based to value-based care.
This workshop will focus on teaching you how to help investigators focus their technology disclosures, funding pitches, and other presentations on the three key factors crucial to gaining interest and commitment: commercial potential, technical merit and investigator willingness to assist.